Literature DB >> 21388335

Direct autologous bone marrow-derived stem cell transplantation for ischemic heart disease: a meta-analysis.

Yanting Wen1, Li Meng, Jun Xie, Jian Ouyang.   

Abstract

OBJECTIVE: Previous evaluation of intracoronary autologous bone marrow-derived stem cell (BMSCs) therapy following ischemic heart disease (IHD) suggested improvement of cardiac functional parameters. We performed a meta-analysis to provide systematic assessment of the safety and efficacy of direct (intramyocardial or endomyocardial) BMSCs transplantation in patients with IHD. RESEARCH DESIGN AND METHODS: Randomized controlled Trials (RCTs) were identified in the MEDLINE (approximately Oct. 2010), the Cochrane Central Register of Controlled Trials (Central) (approximately Oct. 2010), EMBASE (approximately Oct. 2010), and EBSCO (approximately Oct. 2010), reviews, and reference lists of relevant articles. Weighted mean difference (WMD) was calculated for changes in left ventricular ejection fraction (LVEF), left ventricular end-diastolic and end-systolic volumes (LVEDV and LVESV) by using a fixed effects model.
RESULTS: Eight RCTs with 307 participants were eligible. Compared with controls, direct BMSCs transplantation improved LVEF (8.4%, 95% CI, 6.49 to 10.31%; p < 0.01), reduced LVESV and LVEDV (-14.85 ml, 95% CI, -27.29 to -2.41 ml, p = 0.02 and -12.79 ml, 95% CI, -24.94 to -0.65 ml, p = 0.04, respectively).
CONCLUSIONS: This meta-analysis suggests that direct BMSCs transplantation is associated with moderate but significant improvements over regular therapy in cardiac functional parameters in patients with IHD, and supports conducting further RCTs of a higher quality.

Entities:  

Mesh:

Year:  2011        PMID: 21388335     DOI: 10.1517/14712598.2011.560567

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  12 in total

1.  Safety and feasibility for pediatric cardiac regeneration using epicardial delivery of autologous umbilical cord blood-derived mononuclear cells established in a porcine model system.

Authors:  Susana Cantero Peral; Harold M Burkhart; Saji Oommen; Satsuki Yamada; Scott L Nyberg; Xing Li; Patrick W O'Leary; Andre Terzic; Bryan C Cannon; Timothy J Nelson
Journal:  Stem Cells Transl Med       Date:  2015-01-05       Impact factor: 6.940

2.  Bone Marrow-Derived Mesenchymal Stem Cells Improve Diabetic Neuropathy by Direct Modulation of Both Angiogenesis and Myelination in Peripheral Nerves.

Authors:  Ji Woong Han; Dabin Choi; Min Young Lee; Yang Hoon Huh; Young-sup Yoon
Journal:  Cell Transplant       Date:  2015-05-13       Impact factor: 4.064

Review 3.  Stem cell therapies for the treatment of radiation-induced normal tissue side effects.

Authors:  Marc Benderitter; Fabio Caviggioli; Alain Chapel; Robert P Coppes; Chandan Guha; Marco Klinger; Olivier Malard; Fiona Stewart; Radia Tamarat; Peter van Luijk; Charles L Limoli
Journal:  Antioxid Redox Signal       Date:  2014-02-03       Impact factor: 8.401

Review 4.  Cardiac side population cells: moving toward the center stage in cardiac regeneration.

Authors:  Kazumasa Unno; Mohit Jain; Ronglih Liao
Journal:  Circ Res       Date:  2012-05-11       Impact factor: 17.367

Review 5.  Mesenchymal stem cells for cardiac therapy: practical challenges and potential mechanisms.

Authors:  Timothy J Cashman; Valerie Gouon-Evans; Kevin D Costa
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

6.  Comparison of the myocardial clearance of endothelial progenitor cells injected early versus late into reperfused or sustained occlusion myocardial infarction.

Authors:  Andrea J Mitchell; Eric Sabondjian; Kimberley J Blackwood; Jane Sykes; Lela Deans; Qingping Feng; Robert Z Stodilka; Frank S Prato; Gerald Wisenberg
Journal:  Int J Cardiovasc Imaging       Date:  2012-06-27       Impact factor: 2.357

Review 7.  Challenges for heart disease stem cell therapy.

Authors:  Jane Hoover-Plow; Yanqing Gong
Journal:  Vasc Health Risk Manag       Date:  2012-02-17

8.  Cardiomyogenic differentiation-independent improvement of cardiac function by human cardiomyocyte progenitor cell injection in ischaemic mouse hearts.

Authors:  Melina C den Haan; Robert W Grauss; Anke M Smits; Elizabeth M Winter; John van Tuyn; Daniël A Pijnappels; Paul Steendijk; Adriana C Gittenberger-De Groot; Arnoud van der Laarse; Willem E Fibbe; Antoine A F de Vries; Martin J Schalij; Pieter A Doevendans; Marie-José Goumans; Douwe E Atsma
Journal:  J Cell Mol Med       Date:  2012-07       Impact factor: 5.310

Review 9.  Intracavernous administration of bone marrow mononuclear cells: a new method of treating erectile dysfunction?

Authors:  Thomas E Ichim; Timothy Warbington; Octav Cristea; Joseph L Chin; Amit N Patel
Journal:  J Transl Med       Date:  2013-06-09       Impact factor: 5.531

10.  Epicardial delivery of autologous atrial appendage micrografts during coronary artery bypass surgery-safety and feasibility study.

Authors:  Annu Nummi; Tuomo Nieminen; Tommi Pätilä; Milla Lampinen; Miia L Lehtinen; Sari Kivistö; Miia Holmström; Erika Wilkman; Kari Teittinen; Mika Laine; Juha Sinisalo; Markku Kupari; Esko Kankuri; Tatu Juvonen; Antti Vento; Raili Suojaranta; Ari Harjula
Journal:  Pilot Feasibility Stud       Date:  2017-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.